GPR37 ligands
membraneous GPR37
GPR37 agonism
aggregated GPR37
GPR37 label LBs
atomic structures of GPR37
single molecule trafficking of GPR37
PSAP
Prosaposin
treatment of synucleinopathies
Î±-synuclein
intracellular lysosomal enzyme function
pathological hallmark of PD
PD-linked gene products
neuroprotective protein
s disease
cellular injury
relative contributions of improved lysosomal function
intracellular receptor accumulation
co-factor of GBA
interference of disease progression
neurotrophic fragment prosaptide
secreted following cellular stress
saposin C
potential use
high propensity
technological advancements of fluorescence correlation spectroscopy
drug development
insights
DJ
cue dopamine neurons
incl Parkinson
mechanistic understanding
aggregation
diagnosis
Lewy bodies
GPCRs
neuroprotection
PET tracers
Novel applications
GPCR multimerization
autopsy studies
major constituent
dimer formation
survival pathways
LRRK2
analysis
complex
breakthrough
underlying pathogenic process
neurotoxicity
prosaptides
cGPR37KO mice
programme
plasma membrane
agonists
results
addition